Rare, disseminated Kaposi sarcoma in advanced HIV with high-burden pulmonary and skeletal involvement.
Stephen P ConnollyJonathan McGrathJane SuiEavan G MuldoonPublished in: BMJ case reports (2021)
We describe the case of a 30-year-old man who presented to our institution with hypoxia and widespread pulmonary infiltrates managed initially as COVID-19 before receiving a new diagnosis of HIV-associated Kaposi sarcoma (KS) with widespread pulmonary and skeletal involvement. Initial differential diagnoses included Pneumocystis jirovecii pneumonia, disseminated mycobacterial infection and bacillary angiomatosis. A bone marrow biopsy showed heavy infiltration by spindle cells, staining strongly positive for human herpes virus-8 (HHV-8) and CD34, suggesting symptomatic, disseminated KS as the unifying diagnosis. The patient commenced cytotoxic therapy with weekly paclitaxel, with a clinical and radiological response. To our knowledge, this case is among the most severe described in the literature, which we discuss, along with how COVID-19 initially hindered developing a therapeutic allegiance with the patient.
Keyphrases
- pulmonary hypertension
- coronavirus disease
- antiretroviral therapy
- hiv positive
- sars cov
- bone marrow
- hiv infected
- endothelial cells
- hiv testing
- human immunodeficiency virus
- case report
- hepatitis c virus
- hiv aids
- induced apoptosis
- men who have sex with men
- healthcare
- mycobacterium tuberculosis
- systematic review
- mesenchymal stem cells
- early onset
- cell cycle arrest
- south africa
- intensive care unit
- induced pluripotent stem cells
- stem cells
- ultrasound guided
- respiratory failure
- cell death
- flow cytometry
- smoking cessation
- pluripotent stem cells
- endoplasmic reticulum stress
- community acquired pneumonia